| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.8M | -8.2% |
| Cost of Revenue | $14.1M | -15.4% |
| Gross Profit | $3.6M | +37.5% |
| R&D Expense | $0 | — |
| SG&A Expense | $1.2M | -47.4% |
| Operating Income | $2.4M | +319.9% |
| Pre-tax Income | $1.2M | +227.8% |
| Income Tax | $4K | -94.8% |
| Net Income | $1.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39K | -93.6% |
| Accounts Receivable | $10.4M | +46.0% |
| Current Assets | $10.9M | +9165.2% |
| Total Assets | $25.6M | +649.2% |
| Current Liabilities | $18.7M | +32.8% |
| Total Liabilities | $20.2M | +510.4% |
| Stockholders' Equity | $3.5M | +208.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | -45.8% |
| Capital Expenditures | $13K | +0.0% |
| Investing Cash Flow | -$885K | -100.8% |
| Financing Cash Flow | $1.7M | +101.5% |
| Free Cash Flow | -$1.4M | -45.2% |
| +218.8% |
| EPS (Basic) | $0.08 | +157.1% |
| EPS (Diluted) | $0.02 | +114.3% |